Yayoi Nakayama

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 1

Top Topics

Clinical Practice

Top Venues

Expert opinion on drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Kohei Kaku, Yayoi Nakayama, Junko Yabuuchi, Yusuke Naito, Keizo Kanasaki
Safety and effectiveness of empagliflozin in clinical practice as monotherapy or with other glucose-lowering drugs in Japanese patients with type 2 diabetes: subgroup analysis of a 3-year post-marketing surveillance study. Expert opinion on drug safety (2023)